|
Index of reports
> Life Threatening Events (12)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Visipaque (Iodine Intravascular) life threatening events. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Visipaque side effects in 72 year old female
Reported by a health professional (non-physician/pharmacist) from Canada on 2012-08-13
Patient: 72 year old female
Reactions: Burning Sensation, Vomiting, Nausea, Anaphylactic Reaction, Chest Pain, Swollen Tongue
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Visipaque
Indication: Liver Disorder
Start date: 2012-07-30
End date: 2012-07-30
Visipaque
Indication: Diagnostic Procedure
Possible Visipaque side effects in female
Reported by a health professional (non-physician/pharmacist) from Denmark on 2012-04-18
Patient: female, weighing 60.0 kg (132.0 pounds)
Reactions: Anaphylactoid Shock
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Visipaque
Possible Visipaque side effects in male
Reported by a health professional (non-physician/pharmacist) from France on 2012-03-30
Patient: male
Reactions: Nausea, Clonus, Bradycardia, Hypoaesthesia, Cardiac Arrest, Neurogenic Shock
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Aetoxisclerol
Start date: 2010-11-09
End date: 2010-11-09
Visipaque
Indication: Varicocele Repair
Start date: 2010-11-09
End date: 2010-11-09
Other drugs received by patient: Lidocaine
Possible Visipaque side effects in male
Reported by a physician from France on 2012-03-12
Patient: male
Reactions: Hypotension, Respiratory Arrest, Bradycardia, Erythema, Cardiac Arrest
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Heparin Sodium
Indication: Arteriogram Coronary
Start date: 2012-02-03
End date: 2012-02-03
Isoptin
Dosage: 5 mg / 2 ml, 1 df once/single administration
Indication: Arteriogram Coronary
Start date: 2012-02-03
End date: 2012-02-03
Visipaque
Dosage: 270 mg of iodine / ml, 210 ml once/single administration
Indication: Arteriogram Coronary
Start date: 2012-02-03
End date: 2012-02-03
Xylocaine
Dosage: once/single administration
Indication: Arteriogram Coronary
Start date: 2012-02-03
End date: 2012-02-03
Other drugs received by patient: Clopidogrel Bisulfate and Aspirin; Carvedilol; Isosorbide Dinitrate; Perindopril Erbumine; Atorvastatin; Nexium
Possible Visipaque side effects in 60 year old female
Reported by a individual with unspecified qualification from France on 2012-03-05
Patient: 60 year old female
Reactions: Confusional State, Ischaemic Stroke, Transient Global Amnesia, Hypertension
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Cortivasol (Altim)
Start date: 2011-03-11
End date: 2011-03-11
Visipaque
Indication: Product Used FOR Unknown Indication
Start date: 2011-03-11
End date: 2011-03-11
Possible Visipaque side effects in female
Reported by a physician from Germany on 2012-02-29
Patient: female, weighing 55.0 kg (121.0 pounds)
Reactions: Pneumonia, Rhabdomyolysis, Aphasia, Systemic Inflammatory Response Syndrome, Nervous System Disorder, Lactic Acidosis, Delirium, Septic Shock
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Visipaque
Possible Visipaque side effects in 70 year old female
Reported by a individual with unspecified qualification from France on 2012-02-10
Patient: 70 year old female
Reactions: Dyspnoea, Rales, Atrial Fibrillation, Hypoxia, Fall, Spinal Column Injury, Respiratory Distress, Arrhythmia
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Visipaque
Other drugs received by patient: Bisoprolol Fumarate (Cardensiel); Cordarone; Fenofibrate; Amlodipine Besylate; Chondoitin Sulfate Sodium (Chondrosulf); Zolpidem; Panadeine (Efferalgan Codeine) (Codeine Phosphate); Acetaminophen; Pentxifylline (Previscan) (Pentoxifylline); Escitalopram Oxalate (Seroplex); Forosemide (Lasix) (Furosemide); Citalopram Hydrobromide
Possible Visipaque side effects in 70 year old female
Reported by a individual with unspecified qualification from Denmark on 2012-01-30
Patient: 70 year old female, weighing 60.0 kg (132.0 pounds)
Reactions: Pancreatic Carcinoma
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Visipaque
Possible Visipaque side effects in 72 year old female
Reported by a health professional (non-physician/pharmacist) from Germany on 2012-01-23
Patient: 72 year old female, weighing 55.0 kg (121.0 pounds)
Reactions: Aphasia, Systemic Inflammatory Response Syndrome, Lactic Acidosis, Septic Shock
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Visipaque
Possible Visipaque side effects in 73 year old male
Reported by a pharmacist from United States on 2012-01-09
Patient: 73 year old male, weighing 102.5 kg (225.5 pounds)
Reactions: Unresponsive To Stimuli, Anaphylactic Reaction
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Visipaque
Other drugs received by patient: Bicalutamide; Midazolam; Clonidine; Losartan Potassium; Nisoldipine; Fentanyl; Spironolactone; Simvastatin; Zolpidem; Acetaminophen; Advair Diskus 250 / 50; Oxybutynin; Albuterol
Possible Visipaque side effects in 84 year old female
Reported by a individual with unspecified qualification from Norway on 2011-12-01
Patient: 84 year old female
Reactions: Cardio-Respiratory Arrest, Circulatory Collapse
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Visipaque
Dosage: 100 ml, single dose, intravenous
Indication: Spinal Column Injury
Start date: 2011-11-11
End date: 2011-11-11
Visipaque
Dosage: 100 ml, single dose, intravenous
Indication: Anticoagulant Therapy
Start date: 2011-11-11
End date: 2011-11-11
Possible Visipaque side effects in 60 year old female
Reported by a health professional (non-physician/pharmacist) from France on 2011-11-15
Patient: 60 year old female
Reactions: Renal Artery Fibromuscular Dysplasia, Arterial Disorder, Pyrexia, Headache, Serum Ferritin Increased, Renal Ischaemia, Ehlers-Danlos Syndrome, Vertebral Artery Stenosis, Chest Pain, Coronary Artery Occlusion, Vascular Pseudoaneurysm, Angiodysplasia, Ischaemic Stroke, Troponin Increased, Carotid Artery Dissection, Antinuclear Antibody Positive, Renal Artery Dissection, Transient Global Amnesia, Artery Dissection, Hypertension, Inflammation
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Cortivasol (Altm) (Cortivasol)
Dosage: epidural
Start date: 2011-03-11
End date: 2011-03-11
Visipaque
Dosage: 10 ml, single, dose, epidural
Indication: Product Used FOR Unknown Indication
Start date: 2011-03-11
End date: 2011-03-11
|
